Michael A Belfort
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michael A Belfort sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Michael A Belfort: 4 sponsored US clinical trials, 2 recruiting.
Michael A Belfort sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Congenital Diaphragmatic Hernia, with 2 trials.
Upper-quartile sponsor footprint
Michael A Belfort sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases
NCT05672849
Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH
NCT03980717
'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
NCT02875860
Fetal Endotracheal Occlusion (FETO) in Severe and Extremely Severe Congenital Diaphragmatic Hernia
NCT00881660
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Michael A Belfort pipeline
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Congenital Diaphragmatic Hernia (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michael A Belfort: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Michael A Belfort sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Michael A Belfort page
4 registered trials is a research-attention snapshot, not an endorsement of Michael A Belfort or any single study.
- 2 of Michael A Belfort's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Diaphragmatic Hernia is the condition Michael A Belfort studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Diaphragmatic Hernia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Michael A Belfort pipeline card: 4 registered trials from official public datasets.Report a data error.